Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH
A standard concentration behaves like a much stronger product on freshly needled skin
Because controlled clinical safety trials are lacking, healthcare professionals should consistently frame BPC-157 as a research compound rather than an established therapeutic intervention
However, the complexity of human coagulation disorders and potential for serious adverse events necessitate extremely cautious clinical investigation with comprehensive safety monitoring
It is however important to note that human clinical trials are still limited and side effects, as above, have been reported
Understanding these helps determine whether the peptide is appropriate for specific situations